Transcript Highlights:

• I wanted to give a little bit of testimony as a user of the program.
• I wanted to give a little bit of testimony as a user of the program.
• increase in fee becomes a financial burden on business owners.
• First, it caps the municipal franchise fee. It sets it currently at 2%.
• Let's say that there's a fee because it is an overflowing dumpster.

Bills: HB5057 , HB4519 , HB5033 , HB3997 , HB 1237 , HB1904 , HB4400 , HB 1227

Committee: House Environmental Regulation

Keywords: solid waste management, exclusive contracts, public agency, contract amendment, notification requirements, Texas Health and Safety Code, Texas Emissions Reduction Plan, TERP, air quality, emissions reduction, clean fleet, alternative fuel, natural gas vehicles, hydrogen fuel, hydrogen infrastructure, diesel replacement, fleet grants, TCEQ, Texas Commission on Environmental Quality, clean school buses

Summary: The committee first heard House Bill 1904, which would classify intentionally released helium balloons as litter and create criminal penalties for balloon releases. The author and supportive witnesses argued that balloon releases harm wildlife, livestock, waterways, and infrastructure, and that the bill would close a loophole in current litter law. Several members questioned whether criminal penalties were appropriate, and the author said he was willing to work toward civil penalties and fines instead. No vote was taken, and HB 1904 was left pending. The committee then took up several pending bills and reported them favorably to the full House, including HB 3249, HB 3866, HB 4112, HB 1768, HB 1499, HB 573, and HB 464. These measures dealt with topics such as TCEQ contested-case procedures, outdoor storage containers, high-level radioactive waste, concrete plant permitting and grants, unannounced concrete batch plant inspections, and a scrap tire grant program. Most were adopted with substitutes and passed on recorded votes, generally with unanimous or near-unanimous support. A major portion of the meeting focused on HB 3997, which would create expedited permitting timelines for LNG facilities and related wastewater permits. Industry witnesses said the bill would provide certainty for multibillion-dollar projects without eliminating public participation, while environmental groups opposed parts of the bill that they said could limit contested-case participation and be unrealistic for SOAH timelines. TCEQ staff described the current wastewater permitting process and said some of the bill’s timing provisions could be workable, especially with an expedited fee. The bill was left pending after the author said he would continue working on committee substitute language. The committee also heard HB 1237 on extending the renewal window for expired TCEQ occupational water licenses, and HB 4519, a TERP consolidation bill that would combine several clean transportation grant programs into fewer programs. HB 1237 was left pending without testimony, while HB 4519 drew broad support from environmental and industry witnesses who favored simplifying the program, though some asked for stronger emphasis on particulate matter and hydrogen funding. The committee withdrew the substitute on HB 4519 and left it pending. Finally, HB 5033, which would eliminate the motor vehicle emissions inspection and maintenance program if federal authority changes, drew opposition from environmental and inspection-industry witnesses who warned it would weaken air-quality protections and could remove an important enforcement tool. The author said the bill was intended as a trigger mechanism and would be refined, and HB 5033 was left pending. The committee also heard HB 1227 on municipal solid-waste franchise fees and private-provider access; the author said he would bring a substitute after hearing concerns from cities, and the bill was left pending.

Transcript Highlights:

• of the ways they can do that is to have a... federal firearms licensee to store those weapons for a fee

Bills: HB170 , HB865 , HB748 , HJR112 , HB 1110 , HB1495 , HB786 , HB 1130 , HB170

Committee: House Judiciary & Civil Jurisprudence

Keywords: civil liability, self-defense, force, deadly force, legal immunity, attorney's fees, criminal justice, firearms, liability, veterans, gun ownership, immunity, firearm hold agreement, sexual abuse, nondisclosure, confidentiality, public policy, Trey's Law, parental rights, child upbringing

Transcript Highlights:

• individuals who are found immune from liability under this statute can recover reasonable attorney fees
• otherwise. otherwise justified in their act of self-defense, is stuck paying out-of-pocket attorney's fees
• case. case, we believe particularly this section of the bill that adds in the provision for attorneys fees
• , but inside of this it took three years of my life, it cost me a half a million dollars. in legal fees
• courts, then there is a percentage. of the court security fund that's collected through the court fees

Bills: HB170 , HB865 , HB748 , HJR112 , HB 1110 , HB1495 , HB786 , HB 1130 , HB170

Committee: House Judiciary & Civil Jurisprudence

Keywords: civil liability, self-defense, force, deadly force, legal immunity, attorney's fees, criminal justice, firearms, liability, veterans, gun ownership, immunity, firearm hold agreement, sexual abuse, nondisclosure, confidentiality, public policy, Trey's Law, parental rights, child upbringing

Transcript Highlights:

• The board encourages growth in the number of licenses by actions such as reduced fees for the past four
• We've also actually removed some of the legislative or regulatory barriers to get rid of some permit fees
• They are held to a much higher standard, as far as they are FDA registered, FDA inspected, and generally
• me saying this, some of the peptides don’t really have a legitimate supply of those drugs under the FDA
• any kind of test or get inspections to get that license, or is it just fill out paperwork, pay your fee

Committee: All ALC-OCCUPATIONAL LICENSING REVIEW SUBCOMMITTEE

Summary: The Occupational Licensing Subcommittee reviewed four entities moved up from the July schedule: the State Board of Acupuncture, State Board of Pharmacy, Auctioneer Licensing Board, and Motor Vehicle Commission. For acupuncture, the board described its public-protection role, its small size and limited number of active licenses, and efforts to grow the profession through lower fees and online licensing. Members asked generally about what acupuncture treats, and the review was completed without objection. The Pharmacy Board discussion focused heavily on GLP-1 drugs, compounding pharmacies, home delivery of prescriptions, and enforcement against unsafe or unlicensed distribution. Members raised concerns about access to obesity and diabetes medications, mail-order restrictions, and whether compounding pharmacies and out-of-state entities were properly licensed. The director explained the difference between traditional compounding, sterile compounding, and 503B outsourcing facilities, said the board has issued cease-and-desist orders when needed, and noted that retail pharmacy inspections are currently on a 12- to 15-month cycle. Members also asked about pharmacist impersonation, complaint handling, pharmacy technician registration and training, and whether the state has enough pharmacists, with the board saying Arkansas has a pharmacy in every county but still needs to keep attracting new professionals. The Auctioneer Licensing Board reported no major issues, but members asked about dormant license numbers, exemptions from licensure for charity auctions, personal property sales, and livestock auction barns, and whether the profession has adequate numbers. The director said old license numbers cannot be reissued under the current system, charity auctions and sales of one’s own items are exempt, and the field is generally stable with online auctions helping growth. The Motor Vehicle Commission reported on its licensing of franchise dealers and manufacturers, discussed the revocation and fine against Superior RV after an administrative hearing, and said the business is currently shut down while the commission monitors for possible reentry under a different name. Members also asked about dealer licensing requirements, whether boats are licensed by the commission, and workforce shortages; the director said the biggest need is for service and repair technicians, and the commission awarded $250,000 in grants to 12 high school and college automotive programs this year. The committee concluded all four reviews without objection, asked members to email any recommendations for the final report, and announced the next meeting for September 17 at 1:30 p.m.

Transcript Highlights:

• the Sun Trail system to ask, many of the questions required for the report were conducting voluntary user
• Average duration of usage distance traveled and most importantly, the amount of money users are spending
• Port development now learning from these types of exercises enabled FDA to to create comprehensive guidance
• But in addition, additive to that will be other locations where we can get a high concentration of users
• for this because there is that local government role as as as we have the increase in air traffic users

Transcript Highlights:

• </c> respond adequately to current FDA respond adequately to current FDA approved<00:04:28.560><c> PTSD
• Congress three times on suicide prevention and granting breakthrough therapies by the FDA.
• This opportunity for Hawaii to the FDA.
• , because there's also requirements about allowing FDA-approved drug use in hospitals.
• Thank you. >> And the FDA does work.

Summary: The committee heard testimony on SB 3025, relating to medical debt, with multiple organizations and individuals, including the Office of Wellness and Resilience, Healthcare Association of Hawaii, Queens Health Systems, the American Cancer Society Cancer Action Network, Aloha Care, Hawaii Health and Harm Reduction, Hawaii Data Collaborative, and Hawaii Appleseed, all speaking in support. No opposition was heard, and the member present had no questions. The committee then took up SB 3199, which would establish a mental health emerging therapies task force. Testimony was overwhelmingly in support, with speakers including veterans, clinicians, researchers, and advocacy groups describing personal experiences with PTSD, depression, traumatic brain injury, and treatment-resistant conditions, and arguing that Hawaii should prepare for regulated access to emerging therapies such as MDMA, psilocybin, ketamine, and ibogaine. The Department of Health and some medical organizations provided comments, and one opposition witness was called but not present. The chair noted broad support, especially from veterans, and no vote was taken during the excerpt. The final measure discussed was SB 3324, relating to Medicaid. The Department of Human Services, Department of Health, Hawaii State Council on Developmental Disabilities, Hawaii Disability Rights Center, Aloha Care, and numerous care-provider and aging/disability organizations testified in support, while one witness was in opposition and several others offered comments. The discussion then moved to SB 2563, relating to homelessness, where the Department of the Attorney General offered comments on specific sections and recommended adopting suggested amendments if the bill proceeds. Additional testimony on SB 2563 began with support from several individuals, including Shelby Pikachu, who emphasized the severity of homelessness and related social problems in the community.

Transcript Highlights:

• Those hormones wouldn't be covered by insurance as they were not FDA approved.
• Last March, I finally started hormone therapy, FDA-approved hormone therapy, after finding a telehealth
• Those hormones wouldn't be covered by insurance as they were not FDA approved.
• I am also a wheelchair user of the transportation for human services.
• I am also a wheelchair user of the transportation for human services.

Committee: Joint Joint Committee on Public Health

Summary: The committee opened by explaining hearing procedures and time limits, then heard testimony on House 2499, a bill to create a public awareness campaign on menopause and related midlife health issues. Supporters, including a nurse, the Massachusetts Commission on the Status of Women, and other advocates, said menopause is widely misunderstood by patients and providers, leading to delayed care, unnecessary suffering, workplace impacts, and inequities in women’s health. Several speakers shared personal experiences with symptoms being dismissed or misdiagnosed and urged the committee to advance the bill. The committee then took testimony on a package of endometriosis bills, including House 2527 and Senate 1564, calling for a task force and broader awareness efforts. Patients, a physician, and advocates described long diagnostic delays, severe pain, infertility, medical gaslighting, and limited access to specialists and effective treatment. They argued for more research, provider education, and a coordinated state strategy, and several asked for favorable reports. The chair also noted the hearing was running behind and extended time to allow more testimony. Later, the committee heard Senate 1579, which would eliminate parental consent and judicial bypass requirements for abortion access for minors under 16. Planned Parenthood representatives, physicians, legal advocates, and students argued the current law creates unnecessary delays and harms vulnerable youth, especially those in unsafe homes or foster care, while supporters said minors can already consent to other reproductive health care. A pro-life witness opposed the bill and emphasized parental involvement and support services. The committee also heard House 2403 and Senate 1560, which would create a Human Service Transportation Consumer Advisory Board; disability advocates and riders described past safety problems and current service gaps, and supported the board as a low-cost way to improve accountability, rider input, and reliability. No votes or final actions were taken in the excerpt.

Transcript Highlights:

• Bill 2265 narrows what Arizona courts may charge criminal defendants by prohibiting various court fees
• It would also limit courts from creating any new fees against criminal defendants unless the legislature
• The Senate amended the bill by removing the limit on courts creating new fees.
• The Senate amended the bill by removing the limit on courts creating new fees against criminal defendants
• for certain waste disposal fees and contributions.

Bills: HB3767 , HB3934 , HB4199 , HB4336 , HB2947 , HB3834 , HB4302 , HB4095 , HB3287 , HB3649 , HB4430 , HB4431 , HB2059 , HB3647 , HB3986 , HB3548 , HB3661 , HB4346 , HB3075 , HB4273 , HB3391 , HB4128 , HB3557 , HB3239 , HB3982 , HB2123 , HB2979 , HB2997 , HB3148 , HB4108 , HB4143 , HB4266 , HB2053 , HB4058 , SR30

Keywords: controlled dangerous substances, controlled substances, drug scheduling, Schedule I, Schedule IV, anti-drug diversion, drug diversion, synthetic opioids, fentanyl analogs, designer drugs, synthetic cannabinoids, benzodiazepines, benzodiazepine analogs, opioids, hallucinogens, depressants, pharmacy regulation, narcotics control, Oklahoma State Bureau of Narcotics and Dangerous Drugs Control, DEA scheduling

Transcript Highlights:

• THREE PROVISIONS THAT DEAL WITH DISQUALIFICATION OF LEGAL ACTIONS, ATTORNEY FEES AND COSTS, ADMINISTRATIVE
• RESPOND TO THERAPIES AUTHORIZED UNDER THIS BILL BUT NOT APPROVED BY THE FDA?
• GETTING AN UNREGULATED TREATMENT VERSUS A REGULATED THERAPY, THERAPY THAT HAS BEEN APPROVED BY THE FDA
• NOT ONLY IS IT NOT FDA APPROVED BUT ALSO INDICATES THE CONTRAINDICATIONS.
• LOTS OF DIFFERENT THINGS WHERE WE HAVE OFF LABEL TREATMENT OPTIONS FOR PATIENTS ON THINGS THAT ARE FDA

Transcript Highlights:

• relating to the enforcement of a defendant's default on the payment of fines, surcharges, assessment fees
• on top of that, and additional fees on top of that.
• Do you know whether this is one of those fees that goes to Clean Elections?
• That is not the purpose of the FDA adverse event system.
• It is to let the FDA determine what is unsafe.

Summary: The Senate Judiciary and Elections Committee approved the minutes from its March 18, 2026 meeting and then took up a long agenda of bills and a clemency nomination. HB 2825, as amended, was heard first. The bill would replace criminal enforcement tools for nonpayment of fines, fees, restitution, and surcharges with a civil collection process, including a required summons and civil default procedures. Supporters said it would streamline restitution collection and reduce costs, while opponents argued it would weaken victims’ rights and remove effective enforcement leverage. The committee adopted the Rogers amendment and passed the bill 5-2. The committee also confirmed Neil McDowell to the Arizona Board of Executive Clemency by a 6-0 vote after hearing his background in corrections and his plans to help the board function efficiently. The committee then passed HB 4070, as amended, 5-2. That bill bars incorporation of corporations whose officers, directors, or trustees have been convicted of sex trafficking or human trafficking, and expands civil liability to those who facilitate trafficking. Supporters framed it as a corporate accountability tool to deter trafficking, while the ACLU opposed it as overbroad and potentially sweeping in people not intended to be covered. HB 2720, which increases penalties for paying or agreeing to pay for sexual conduct and adds a fee to support anti-trafficking services, also passed, 4-3. Supporters, including survivors and law enforcement, said it targets demand and helps victims; opponents warned it could criminalize victims and lacked sufficient safeguards. The committee heard several additional bills. HB 2047 would raise trespass penalties after eviction-related writs of restitution from third-degree to first-degree trespass; the sponsor and constables said it would improve scene safety and encourage law enforcement response. HB 2136 would create new crimes for “civil terrorism” and “subversion” and increase penalties for certain highway obstruction; the ACLU argued it would punish protest and speech critical of government. HB 2406 would make images and recordings of abused children and deceased minors confidential, limit dissemination, and impose civil and criminal penalties for misuse; supporters said it would prevent re-victimization and reduce trauma, while defense and media concerns were raised about access. HB 2415, dealing with kratom and 7-OH products, drew sharply divided testimony over whether the bill is a needed safety regulation or an overbroad ban that could push users to illicit drugs; the transcript ends before a final vote on that bill.

Transcript Highlights:

• Okay, and so the fee is to make the program self-sustaining?
• One of the primary focuses we saw was banning discriminatory fees, chargebacks, and clawbacks.
• Of up to $5,000 per day per violation, as well as reasonable attorney fees and costs.
• That fee has made it possible for us to keep very expensive brand-name medications in stock.
• To wrap up, we are seeing major health care issues for the average user.

Summary: The committee first heard House Bill 2437, which would put the Department of Health’s authority to accredit opioid treatment programs into statute and allow the department to set a fee to cover the cost of those services. The prime sponsor and DOH said the bill would preserve a service that is especially important to tribal and rural providers and would be self-sustaining rather than supported by the general fund. Members asked about the relationship between DOH and HCA and whether the bill would duplicate existing authority; staff and the department said DOH already performs the accrediting role and the bill mainly formalizes that authority and fee-setting power. Public testimony on the bill was then closed. The committee then held an extensive work session on the federal 340B drug pricing program and later opened public testimony on House Bill 2145, which would prohibit manufacturers, distributors, and third-party logistics providers from restricting 340B drug acquisition or delivery and from requiring claims or utilization data as a condition of access. Committee staff and NCSL gave background on how 340B works, recent growth in the program, contract pharmacy issues, and state efforts in other jurisdictions. Testimony on HB 2145 was sharply divided: hospitals, community health centers, tribal representatives, contract pharmacies, and labor groups said the bill would protect safety-net providers, rural access, HIV and behavioral health services, and tribal programs from manufacturer restrictions; business groups, pharmaceutical companies, and employer coalitions argued the program has expanded beyond its original intent, lacks transparency, shifts costs to employers and taxpayers, and should be addressed through federal reform instead. No vote was taken in the excerpt. Finally, the committee heard House Bill 2155, which would bar non-human entities from using nursing titles such as RN, APRN, or LPN or otherwise implying they are licensed nurses. The prime sponsor said the bill is intended to protect patients from being misled by AI systems and to preserve transparency and public safety as health care technology expands. The Washington State Nurses Association testified in support, saying AI can be useful but should not replace nurses or be presented as a licensed professional. A member asked about enforcement and liability, and staff said they would follow up on those details.

Transcript Highlights:

• Uh it's only, it was only last year that the that the, uh, which group was FDA.
• The FDA finally Some of the current research says that the half-life of what I have today is 5 to 10
• And this, I think, is important because when we consider the cost of tipping fees, private landfill..
• The costs associated with getting those from point A to point B are going to be borne by the users of
• For a fee to come and do that required work.

Committee: House Agriculture

Summary: The meeting focused on the use of biosolids on farm and ranch land, with testimony from Oklahoma State University experts, a conservation official, and an engineering representative about the benefits, risks, and regulatory implications. Dr. Lusk described OSU’s long history of soil fertility research and said biosolids can provide nutrients and organic matter, but also may carry contaminants such as PFAS, heavy metals, pharmaceuticals, microplastics, and pathogens. He emphasized that many questions remain unanswered, especially about contaminant uptake into soil, crops, livestock, and humans, and said existing EPA and Oklahoma DEQ regulations address some treatment and application standards but may not fully cover PFAS. Dr. Arnell expanded on nutrient management, explaining that biosolids can function similarly to manure as a fertilizer source, especially for nitrogen and phosphorus, but should be tested, incorporated into soil, and applied under permit conditions to reduce runoff and other losses. He said PFAS testing methods are not yet standardized and that more research is needed to determine sampling protocols, movement in soil, and long-term effects. Committee members asked whether farmers and ranchers should be notified of risks, whether PFAS is currently tested, how many counties use biosolids, and what research would be needed for a dissertation-level study. The witnesses generally agreed that landowners should be informed of known risks and uncertainties, but said the science is still developing. Dr. Arnell said a unified testing method is needed before reliable PFAS monitoring can be done, and suggested that a multi-year study would be required to understand soil movement, crop uptake, and livestock impacts. Greg Scott of the Oklahoma Conservation Commission framed the issue as a waste-management problem, noting that human waste streams contain contaminants and that soil type affects how pollutants move; he said sandy soils pose greater movement risks than clay soils and that current best practice is incorporation, careful timing, and avoiding steep or sensitive sites. He also said PFAS are widespread and not naturally occurring in the way some other compounds are, and that liability and cleanup costs are major concerns. Mary Elizabeth Mock of Garver Engineering focused on the practical and financial consequences of a possible moratorium on land application, saying most of Oklahoma’s biosolids are currently land applied and would otherwise have to go to landfills. She warned that many landfills are nearing capacity, tipping fees could rise sharply, and cities such as Tulsa and Norman could face large increases in disposal costs, which would ultimately be borne by ratepayers and taxpayers. She also said septic system maintenance costs could rise if land application options shrink, potentially leading to deferred maintenance and system failures. Mock urged a tiered, data-driven approach to PFAS regulation and said advanced treatment technologies may help in the future, but they are still emerging and expensive. No votes were taken; the session consisted of presentations and member questions.

Transcript Highlights:

• Bill 2265 narrows what Arizona courts may charge criminal defendants by prohibiting various court fees
• It would also limit courts from creating any new fees against criminal defendants unless the legislature
• The Senate amended the bill by removing the limit on courts creating new fees.
• The Senate amended the bill by removing the limit on courts creating new fees against criminal defendants
• for certain waste disposal fees and contributions.

Summary: The meeting covered seven Senate-amended House bills on the caucus agenda. HB 248 was described as changing prior language about private process servers and, in the Senate strike-everything version, prohibiting more restrictive utilization controls for FDA-approved non-opioid pain medications than those applied to opioid or narcotic drugs, with a repeal date of September 1, 2028. HB 2265 would continue limiting certain court fees charged to criminal defendants, though the Senate removed the provision barring courts from creating new fees without express legislative authorization. HB 2404 would require authorized transporters for certain mental health transports; the sponsor explained the Senate changes delay implementation until 2030 and preserve officer involvement when safety concerns exist. HB 2611 would strengthen DCS group foster home safety rules, including drug screening consequences for employees and additional security standards, with the sponsor emphasizing child safety and accountability. HB 2950 would authorize tourism improvement areas and lodging assessments, with the Senate shifting assessment approval to the governing body and removing some new-business assessment requirements. HB 2986 made multiple ADEQ-related changes, including replacing the recycling fund with the solid waste fee fund and expanding its uses. HB 2995 revised child custody and domestic violence standards to make domestic violence a dominant factor in custody decisions, with Senate amendments adjusting findings, evidence standards, burdens of proof, and adding an emergency clause. Most bills were met with sponsor concurrence and no recorded opposition. HB 2404 drew questions about whether peace officers would still be involved in transports; the sponsor clarified officers would still handle the initial pickup and could be recalled if the person remained high risk or aggressive. HB 2611 was supported as a child-protection measure based partly on recommendations from youth in group homes. HB 2950 was described as a private, opt-in tourism financing tool that would cost taxpayers nothing. HB 2986 was noted as having passed the Senate unanimously. HB 2995 generated the most discussion. Supporters said it addresses coercive control and financial abuse in domestic violence cases and was developed through a lengthy stakeholder process, including court input, to better protect children and families. One member objected that the bill’s wording could sweep in ordinary marital conduct, such as managing finances, making demeaning remarks, or threatening to call police or file for divorce, and urged an amendment to narrow the language. Supporters responded that the bill is aimed at coercive control in custody disputes, that the emergency clause reflects immediate need, and that fixes could be revisited later. The caucus ended with a reminder about a second caucus after floor for the budget bill.

Transcript Highlights:

• We do not have FDA-approved medications for stimulant use disorder yet, though there is ongoing research
• I think while opioid use disorder has multiple FDA-approved treatments, we're certainly seeing a rise
• So they don't have any medications that are FDA-approved.
• I think while opioid use disorder has multiple FDA-improved treatments, we're certainly seeing a rise
• So they don't have any medications that are FDA approved.

Committee: House Substance Abuse Prevention and Treatment Task Force

Transcript Highlights:

• So in April, we got the DOJ final order that placed FDA-approved cannabis products and medical cannabis
• It covers only two types of cannabis products: one, FDA-approved drugs containing Delta-9 THC from the
• The order also imposes regulatory requirements on FDA-approved cannabis products, not very surprising
• There are enforcement concerns regarding a lack of resources at FDA and the U.S.
• Additionally, it provided that no fee will be charged for filing these petitions.

Transcript Highlights:

• That was the bill eliminating what we reference as a junk fee: the fee for what we call loss of use,
• So the idea of bringing back a junk fee after it was removed is a little challenging for me.
• So the idea of bringing back a junk fee after it was removed is a little challenging for me.
• I think it puts people at risk of having to pay these fees when they didn’t do anything wrong.
• Fees under this section may not exceed 30 days. It’s lines 8 and 9 of House Amendment 2.

Summary: The House convened with Girl State participants presiding for part of the session, including introductions of the student leadership and a unanimous voice vote passing House Concurrent Resolution 152 honoring the young women participating in Delaware Girl State. The chamber also welcomed congressional interns and other guests, accepted the prior day’s minutes, and observed a moment of silence for Nathan Cynix and Kara Feeley before prayer and the Pledge of Allegiance. A major portion of the meeting was devoted to tributes for Representative Ron Gray, who was recognized for his 14 years of service and his work on issues such as bond bills, dredging, bike paths, small business, constituent service, and agriculture-related funding. Multiple members from both parties praised his humor, honesty, mentorship, and dedication to the House and his district. Gray responded with extended remarks reflecting on his family legacy, legislative service, and appreciation for colleagues and staff, and the chamber later sang “Take Me Out to the Ball Game” at his request. The House then received communications, including Senate messages returning several bills and informing the chamber of Senate passage of additional measures. Members were also told that the FY27 bond bill, House Bill 500, had been placed on desks as a gift for review. The House read in Consent Agenda S, which included House Bill 476, House Joint Resolution 13, Senate Substitute 1 for Senate Bill 168, Senate Bill 297, Senate Substitute 1 for Senate Bill 319, and Senate Joint Resolution 21, and began a roll call vote on the consent agenda.

Transcript Highlights:

• 00:05:15.280><c> diseases</c><00:05:16.080><c> having</c><00:05:16.400><c> any</c><00:05:16.680><c> FDA
• </c><00:05:17.360><c> approved</c> rare diseases having any FDA approved rare diseases having any FDA
• She also said youth tobacco users are more likely to have these private conversations, so appreciating
• She also said youth tobacco users are more likely to have these private conversations, so appreciating
• She also said youth tobacco users are more likely to have these private conversations, so appreciating

Committee: House Health Finance and Policy

Transcript Highlights:

• certification registration processes in New York and Pennsylvania cited by OPLER predated the 2022 FDA
• I've gotten some emails saying that the FDA requires licensure for hearing aids.
• There's guidance from both of those states and then from the FDA saying this should not change who is
• Well, they would go back to the local jurisdiction to set those fees, fines, and things.
• other than their trust fees.

Committee: Joint Business and Labor Interim Committee

Transcript Highlights:

• So dark patterns are techniques that software developers deploy in designing the user interface that
• Platforms analyzed patterns between my data and the data of millions of users.
• This kind of reward schedule keeps users users constantly scrolling and always looking for that next
• Additionally, the FDA doesn't cover consumer neurotech because it's not a medical device.
• Additionally, the FDA doesn't cover consumer neurotech because it's not a medical device.

Committee: Joint Joint Committee on Advanced Information Technology, the Internet and Cybersecurity

Summary: The committee hearing focused on a package of Massachusetts privacy and technology bills, especially measures to ban the sale of location data, establish a comprehensive consumer data privacy law, and regulate biometric recognition and surveillance pricing. Chairs and sponsors argued that self-regulation has failed, that data brokers and large tech companies routinely collect and monetize sensitive information, and that state action is needed because federal protections are weak or absent. Several speakers tied the bills to reproductive health, gender-affirming care, domestic violence, children’s data, and other sensitive uses of location and biometric information. Supporters included legislators and advocates who backed H. 86/S. 197 (Location Shield), H. 78/S. 45/H. 104/S. 29 (comprehensive privacy bills), H. 99/S. 47 (surveillance pricing in grocery stores), and H. 36/S. 36 (biometric recognition accountability). They emphasized data minimization, bans on selling sensitive data, consumer rights to access, delete, and opt out, and in some cases a private right of action. Several witnesses said Massachusetts should lead or align with other states, while others argued that stronger protections are needed because data can be weaponized by stalkers, anti-abortion actors, abusive partners, insurers, or law enforcement. Industry and coalition witnesses urged the committee to favor a more standardized, interoperable framework modeled on laws already adopted in other states, warning that novel definitions, data-minimization rules, and private rights of action could create compliance burdens, confusion, and costs for businesses, including small businesses. They argued that entity-level exemptions for sectors already covered by federal laws like HIPAA or GLBA promote consistency, and that Attorney General enforcement is preferable to private lawsuits. Committee members questioned witnesses on patchwork concerns, the scope of exemptions, and whether the proposed bills would harm or help consumers and small businesses. No votes or final actions were taken during the hearing; written testimony was noted as due later, and the committee continued taking testimony from multiple panels and virtual witnesses.